Dragojevic S[au] - Search Results

Year	Number of Results
1973	1
1974	1
1988	1
1998	1
2004	3
2005	3
2006	3
2008	1
2009	1
2010	1
2011	4
2012	3
2015	2
2017	1
2018	1
2019	2
2020	1
2021	4
2022	2

1

Benzoxaboroles-Novel Autotaxin Inhibitors.

Kraljić K, Jelić D, Žiher D, Cvrtila A, Dragojević S, Sinković V, Mesić M. Kraljić K, et al. Among authors: dragojevic s. Molecules. 2019 Sep 20;24(19):3419. doi: 10.3390/molecules24193419. Molecules. 2019. PMID: 31547058 Free PMC article.

2

Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers.

Dragojevic S, Ji J, Singh PK, Connors MA, Mutter RW, Lester SC, Talele SM, Zhang W, Carlson BL, Remmes NB, Park SS, Elmquist WF, Krishnan S, Tryggestad EJ, Sarkaria JN. Dragojevic S, et al. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):e54-e62. doi: 10.1016/j.ijrobp.2021.08.003. Epub 2021 Aug 14. Int J Radiat Oncol Biol Phys. 2021. PMID: 34400266 Review.

3

Degradation products of azetidine core G334089 - Isolation, structure elucidation and pathway.

Čikoš A, Dragojević S, Kubiček A. Čikoš A, et al. Among authors: dragojevic s. J Pharm Biomed Anal. 2021 Sep 5;203:114232. doi: 10.1016/j.jpba.2021.114232. Epub 2021 Jun 30. J Pharm Biomed Anal. 2021. PMID: 34246845

4

Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma.

Talele S, Zhang W, Burgenske DM, Kim M, Mohammad AS, Dragojevic S, Gupta SK, Bindra RS, Sarkaria JN, Elmquist WF. Talele S, et al. Among authors: dragojevic s. J Pharmacol Exp Ther. 2021 Dec;379(3):343-357. doi: 10.1124/jpet.121.000845. Epub 2021 Sep 23. J Pharmacol Exp Ther. 2021. PMID: 34556535

5

Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.

Raucher D, Dragojevic S, Ryu J. Raucher D, et al. Among authors: dragojevic s. Front Oncol. 2018 Dec 17;8:624. doi: 10.3389/fonc.2018.00624. eCollection 2018. Front Oncol. 2018. PMID: 30619758 Free PMC article. Review.

6

Investigation of Praziquantel/Cyclodextrin Inclusion Complexation by NMR and LC-HRMS/MS: Mechanism, Solubility, Chemical Stability, and Degradation Products.

Špehar TK, Pocrnić M, Klarić D, Bertoša B, Čikoš A, Jug M, Padovan J, Dragojević S, Galić N. Špehar TK, et al. Among authors: dragojevic s. Mol Pharm. 2021 Nov 1;18(11):4210-4223. doi: 10.1021/acs.molpharmaceut.1c00716. Epub 2021 Oct 21. Mol Pharm. 2021. PMID: 34670371 Free PMC article.

7

Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy.

Dragojevic S, Ryu JS, Raucher D. Dragojevic S, et al. Molecules. 2015 Dec 4;20(12):21750-69. doi: 10.3390/molecules201219804. Molecules. 2015. PMID: 26690101 Free PMC article. Review.

8

Thermally Targeted p50 Peptide Inhibits Proliferation and Induces Apoptosis of Breast Cancer Cell Lines.

Thomas E, Dragojevic S, Price A, Raucher D. Thomas E, et al. Among authors: dragojevic s. Macromol Biosci. 2020 Oct;20(10):e2000170. doi: 10.1002/mabi.202000170. Epub 2020 Jul 30. Macromol Biosci. 2020. PMID: 32734662 Free PMC article.

9

Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery.

Dragojevic S, Turner L, Raucher D. Dragojevic S, et al. Int J Mol Sci. 2022 Feb 19;23(4):2301. doi: 10.3390/ijms23042301. Int J Mol Sci. 2022. PMID: 35216417 Free PMC article.

10

Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.

Dragojevic S, Mackey R, Raucher D. Dragojevic S, et al. Molecules. 2019 Sep 6;24(18):3242. doi: 10.3390/molecules24183242. Molecules. 2019. PMID: 31489879 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results